Market Overview The US acoustic neuroma market is experiencing observation-driven evolution as active surveillance protocols become standard management for small, asymptomatic vestibular schwannomas, changing the treatment paradigm. The US Acoustic Neuroma Market is projected to grow through 2030, driven by increasing recognition that many small acoustic neuromas grow slowly or not at all, with...